Abstract: Antimicrobial compounds of formula I are disclosed:

Abstract: Antimicrobial compounds of formula I are disclosed: R1—X—R2 wherein X is a group comprising of from about 4 to about 10 amino acids, wherein at least one of the amide (—CONH—) linkages is replaced by —CRaRaRbNRc—; Ra, Rb, and Rc are each independently hydrogen, (C1-C6)alkyl, (C2-C6)alkenyl, (C2-C6)alkynyl, (C3-C8)cycloalkyl, (C1-C6)alkoxycarbonyl, aryl, or heterocycle; and R1 and R2 are each independently hydrogen, a saccharide, a lipid, a solubilizing agent, or a suitable protecting group; or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions comprising such compounds or salts, and methods of using such compounds or salts to treat a bacterial infection.

Abstract: A method of preparing cyclic peptide mixtures via side chain or backbone and solid phase synthesis. The cyclic peptide mixtures form libraries that are useful for screening purposes featuring the attachment of an amino acid to a solid support through its side chain or backbone in order to mimic solution cyclization procedures with linear peptides. In the preferred embodiment, Boc chemistry is used for peptide synthesis, wherein the initial attachment of a trifunctional amino acid is by the aspartyl side chain (with OFm for alpha-carboxyl protection). Cyclization is performed using uronium reagents with racemization suppressant, and a strong acid (HF) is used for deprotection and cleavage. The strategy has been used for the preparation of a series of cyclic peptide mixtures. The procedure is expandable to include at least twenty different amino acids at each position (except the resin linked position where most attachments are by Asp, Lys, Glu, or Orn).

Abstract: The present invention relates to compounds of the formula:R.sub.1 SCH(R.sub.2)CH(R.sub.3)CO-AA.sub.1 ?AA.sub.2 !.sub.m ?AA.sub.3 !.sub.n --X orHSCH.sub.2 ?CH.sub.2 CH(CH.sub.3).sub.2 !CO--Nal--NH.sub.2wherein Nal is L-3-(2-naphthyl)alanine;m is the integer 0 or 1; n is an integer from 0-2;AA.sub.1 is a non-polar hydrophobic aromatic amino acid;AA.sub.2 is alanine, glycine, leucine, isoleucine or phenylalanine;AA.sub.3 is one of the twenty naturally occurring amino acids, preferably glutamine or arginine;R.sub.1 is hydrogen, alkyl having from 1-10 carbon atoms, alkanoyl having from 2-10 carbon atoms, or aroyl having from 7-10 carbon atoms;R.sub.2 is hydrogen or alkyl having from 1-6 carbon atoms;R.sub.3 is hydrogen, alkyl having from 2-10 carbon atoms, cycloalkyl having from 3-6 carbon atoms, aryl or arylalkyl, wherein aryl moieties have from 6-10 carbon atoms;X is NH.sub.2, OH, OCH.sub.3 or OCH.sub.2 CH.sub.3 ;and salts thereof.

Abstract: This invention is directed to a collagenase inhibitor of the formula: ##STR1##

Abstract: This invention is directed to a collagenase inhibitor of the formula: ##STR1##

Abstract: There are disclosed thionated analogues of thyrotropin releasing hormone, having the formula: ##STR1## wherein, Q, W, X and Y, same or different, are oxygen or sulfur, with the proviso that at least one of Q, W, X and Y is always sulfur;Z is lower alkyl or (4-imidazolyl)methyl; and the pharmaceutically acceptable salts thereof. The disclosed compounds highly and selectively bind to TRH binding sites in animal tissues, and their utility in treating a variety of diverse physical conditions is disclosed. Pharmaceutical compositions containing the compounds are also disclosed.